JESSICA RIGGINS: Open Payments
NPI 1104276294 · HALFMOON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 24 payments from 6 companies in 2025. Trend: 2023 $503 · 2024 $369 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $313 |
| Lilly USA, LLC | 4 | $84 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Ascendis Pharma Endocrinology Inc | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $16 |
Products named: Wegovy, ZEPBOUND, Ozempic, Rybelsus, MOUNJARO, CONTRAVE, Yorvipath, GVOKE HYPOPEN.
Industry payments across NY — which companies pay providers there.
